Table 2. Seasonality and Staphylococcus aureus Skin Infections.
Type of Infection | Age | Locale | Seasonality | Author |
CA*-associated S. aureus ‘boil infections’ | All | Nigeria | Peak incidence: 33% of cases occurred during warmest recorded months (Jan–Mar) | [15] |
CA-associated pyoderma | All | India | Peak incidence: Summer (40% of cases occurred Jun–Aug) | [16] |
CA-associated pyoderma | All | Malawi | Peak incidence: Summer (Dec–Apr) | [17] |
CA-associated pyoderma | Pediatric | India | Peak incidence: 68% of cases ‘reported during the hot and humid months of Jun–Sep' | [18] |
Dermatitis cruris pustulosis exacerbation (87% culture-positive for S. aureus) | All | India | Peak incidence: Summer (87% of cases) | [19] |
Impetigo | Pediatric | Nether-lands | Peak incidence in 1987 & 2001: Summer (‘incidence was significantly higher in summer’) | [20] |
Impetigo | Pediatric | United Kingdom | Peak incidence: ‘Late Summer’ (∼37% of cases Jul–Sep; seasonal effect [p = 0·02]; correlation between impetigo andmean temperature the previous month [r = 0·55; p = 0·001]) | [3] |
Impetigo | Pediatric | United Kingdom | Peak incidence: Autumn (Oct peak in 4 of 5 years studied); ∼1–2 months after the month with the highest average temperature | [21] |
Impetigo | Pediatric | Alabama | Peak Incidence: Summer (33% of cases occurred in Aug; monitored Jul–Jan rather than the calendar year) | [22] |
Impetigo | Pediatric | Australia | Peak incidence: 79% of cases occurred in summer and autumn | [23] |
Impetigo | Pediatric | Pakistan | Peak incidence: Summer (2–3 fold increased incidence/100 person-wks of impetigo in Jul compared with May, Sep, or Oct) | [24] |
Impetigo bullosa due to fusidic acid-resistant S. aureus | Pediatric | Norway | Peak incidence: ‘Marked seasonal fluctuation with the highest prevalence in early autumn’ (52% of 2001 cases in Aug) | [25] |
*CA = Community-associated.